reSee.it - Related Video Feed

Alzheimer's disease has traditionally been viewed as a result of amyloid beta plaques and neurofibrillary tangles in the brain, which can only be confirmed postmortem. This has led to a need for a paradigm shift in understanding the disease. Emerging research suggests a metabolic theory of cognitive decline, indicating that markers of metabolic health, such as fasting insulin and glucose levels, may be more predictive of Alzheimer's risk than age. A Finnish study found that fasting insulin was a stronger predictor of Alzheimer's than age. The hippocampus, crucial for memory and learning, relies on glucose and ketones for energy. Insulin regulates glucose transport in the hippocampus, and as insulin resistance develops, the brain struggles to access glucose, leading to an energy deficit. This has led some researchers to label Alzheimer's as "type 3 diabetes," highlighting the connection between insulin resistance and cognitive decline. Insulin's role extends beyond glucose control; it affects every cell in the body. Chronic high carbohydrate intake leads to elevated insulin levels, causing insulin resistance and metabolic dysfunction. This dysfunction can manifest in various health issues, including cognitive decline, PCOS, and erectile dysfunction, all linked to insulin resistance. Research indicates that even in early cognitive decline, glucose metabolism in the brain is impaired while ketone metabolism remains intact. Studies show that dietary changes, particularly reducing carbohydrates and increasing healthy fats, can improve cognitive function. The food we consume plays a critical role in either exacerbating or alleviating chronic diseases, including Alzheimer's. To combat cognitive decline, individuals should focus on improving metabolic health through dietary changes, such as reducing refined carbohydrates and increasing healthy fats. This approach not only addresses Alzheimer's risk but also enhances overall well-being. The message is one of empowerment: individuals can take control of their health through informed dietary choices.

Alzheimer's disease typically takes about 20 years from the onset of pathophysiology to diagnosis. Cognitive improvement is possible at any age by addressing underlying causes, such as unrecognized toxins or pathogens. Notably, nocturnal oxygen desaturation is critical; studies show that low oxygen levels during sleep correlate with brain volume loss. Many people are unaware of their declining oxygen saturation due to conditions like sleep apnea, which can starve the brain. As the aging population grows, cognitive decline has become a primary concern, surpassing cancer. Currently, around 5.6 million Americans have an Alzheimer's diagnosis, but projections suggest that 45 million could eventually die from the disease. Factors like obesity, poor immunity, and low vitamin D levels increase risks for both Alzheimer's and COVID-19. The complexity of Alzheimer's means it cannot be attributed to a single cause. Early lifestyle factors in younger individuals can increase future risk. The disease is often linked to inflammation, toxins, and hormonal deficiencies. For instance, insulin resistance contributes to cognitive decline through inflammation and reduced trophic support. Addressing these factors early can prevent or reverse symptoms. Dale Bredesen emphasizes the importance of personalized approaches to treatment, identifying root causes, and creating targeted interventions. His research indicates that multiple contributors, including toxins from mold and environmental factors, must be addressed for effective treatment. The Bredesen protocol encourages individuals over 45 to undergo a "cognoscopy" to assess cognitive health proactively. Success stories illustrate that individuals can improve their cognitive function by following a comprehensive protocol that includes lifestyle changes, dietary adjustments, and addressing environmental toxins. The narrative of patients like Deborah, who recognized early signs of cognitive decline and sought intervention, highlights the importance of early detection and personalized care. The overarching message is that Alzheimer's can be an optional disease with appropriate preventive measures and lifestyle adjustments.

Alzheimer's disease is projected to affect 45 million Americans, with lifestyle factors like diet and insulin resistance playing critical roles in brain health. The Western diet accelerates brain aging, while fasting can help reverse these conditions. Insulin resistance occurs when the body struggles to manage glucose, leading to various metabolic issues. This condition can manifest years before glucose levels rise, making it essential to monitor waist circumference and lipid panels as early indicators. The link between insulin resistance and Alzheimer's is significant; elevated glucose and insulin levels can hinder the brain's ability to clear amyloid plaques, which are associated with Alzheimer's. Chronic inflammation and insulin resistance create a perfect storm for neurodegenerative diseases. To reduce Alzheimer's risk, individuals should evaluate their lifestyle and health metrics, focusing on triglyceride levels, HDL cholesterol, liver function tests, and inflammation markers. Dietary habits, particularly carbohydrate intake, are crucial in managing insulin resistance. Many people, especially those from South Asian backgrounds, may consume healthy foods that still contribute to insulin resistance due to high carbohydrate content. The concept of "skinny fat" highlights that individuals can appear thin yet have high visceral fat, which is more harmful than subcutaneous fat. This phenomenon is particularly prevalent in certain ethnic groups, where even small amounts of excess weight can lead to significant metabolic issues. The discussion emphasizes the importance of personalized nutrition and exercise, as well as the need for awareness about the impact of modern diets and sedentary lifestyles on health. Fasting and meal sequencing can help manage blood sugar levels, and incorporating more vegetables and healthy fats into meals can mitigate the effects of carbohydrates. Women are disproportionately affected by Alzheimer's, with hormonal changes during menopause contributing to cognitive decline. Estradiol, a key hormone, supports brain health, and its decline can lead to increased risk for Alzheimer's. Understanding these changes is vital for prevention, and early intervention can significantly impact long-term health outcomes. The conversation also touches on the importance of addressing environmental toxins, such as heavy metals and mold, which can contribute to cognitive decline. Regular monitoring and proactive health measures, including brain scans and lifestyle modifications, are essential for reducing the risk of Alzheimer's and other neurodegenerative diseases. Overall, the key takeaways include the importance of diet, exercise, hormonal health, and environmental factors in maintaining cognitive function and preventing Alzheimer's disease. Individuals are encouraged to take proactive steps in their health journey, focusing on personalized strategies that align with their unique needs and backgrounds.

Dr. Nathan Bryan discusses the critical role of nitric oxide (NO) in preventing chronic diseases, particularly cardiovascular disease, which is the leading cause of death globally. The loss of NO production in blood vessels precedes structural changes associated with cardiovascular issues, highlighting its importance in maintaining vascular health. Bryan identifies four hallmarks of disease: low blood flow (hypoxia), inflammation, oxidative stress, and immune dysfunction, all of which are mitigated by NO. He emphasizes that understanding the root causes of diseases is essential for developing effective therapies, positioning NO as the "Holy Grail" of health and longevity. Bryan connects NO deficiency to various diseases, including Alzheimer's, where reduced blood flow in the brain leads to cognitive decline. He points out that common medications, particularly proton pump inhibitors (PPIs), disrupt NO production and are linked to increased risks of heart attacks and Alzheimer's. Bryan explains that PPIs inhibit stomach acid production, which is necessary for nutrient absorption and NO synthesis. He warns that long-term use of these drugs can lead to serious health issues, including kidney disease and osteoporosis. He advocates for dietary changes, emphasizing the dangers of sugar consumption, which contributes to insulin resistance and inflammation, both risk factors for Alzheimer's. Lifestyle factors such as a sedentary lifestyle, poor diet, and the use of mouthwash that kills beneficial oral bacteria also contribute to low NO levels. Bryan recommends focusing on nutrient-dense foods, particularly dark leafy greens, and suggests that regular exercise can stimulate NO production. He highlights the importance of maintaining a healthy oral microbiome for systemic health and NO production. Bryan introduces his nitric oxide supplement, which directly provides the gas to improve circulation and overall health. He stresses that while supplements can help, they should not replace a healthy lifestyle. He concludes by encouraging proactive health measures, including regular testing for blood sugar and insulin levels, to prevent chronic diseases. Bryan's ongoing research aims to develop FDA-approved drugs targeting ischemic heart disease and Alzheimer's, reinforcing the need for a scientific approach to NO therapy.